Cargando…

Natriuresis‐guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium‐based treatment algoritHm in Acute Heart Failure (PUSH‐AHF) trial

AIMS: Insufficient diuretic response frequently occurs in patients admitted for acute heart failure (HF) and is associated with worse clinical outcomes. Recent studies have shown that measuring natriuresis early after hospital admission could reliably identify patients with a poor diuretic response...

Descripción completa

Detalles Bibliográficos
Autores principales:	ter Maaten, Jozine M., Beldhuis, Iris E., van der Meer, Peter, Krikken, Jan A., Coster, Jenifer E., Nieuwland, Wybe, van Veldhuisen, Dirk J., Voors, Adriaan A., Damman, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd. 2022
Materias:	Study Design
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306663/ https://www.ncbi.nlm.nih.gov/pubmed/34791756 http://dx.doi.org/10.1002/ejhf.2385

Ejemplares similares

Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial
por: ter Maaten, Jozine M., et al.
Publicado: (2023)

Clinical importance of urinary sodium excretion in acute heart failure
por: Damman, Kevin, et al.
Publicado: (2020)

Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX‐AHF‐2 study
por: Teerlink, John R., et al.
Publicado: (2017)

Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR‐AHF
por: Palazzuoli, Alberto, et al.
Publicado: (2017)

Efficacy of early initiation of ivabradine treatment in patients with acute heart failure: rationale and design of SHIFT‐AHF trial
por: Su, Yang, et al.
Publicado: (2020)

Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure
por: Boorsma, Eva M., et al.
Publicado: (2020)

Urinary sodium evaluation: the missing target for diuretic treatment optimization in acute heart failure patients? Reply
por: Damman, Kevin, et al.
Publicado: (2020)

Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study
por: Metra, Marco, et al.
Publicado: (2010)

Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF
por: Metra, Marco, et al.
Publicado: (2013)

Disconnect between the effects of serelaxin on renal function and outcome in acute heart failure
por: Beldhuis, I. E., et al.
Publicado: (2023)

Sodium–glucose co‐transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial
por: Tromp, Jasper, et al.
Publicado: (2021)

Rationale and design of the AUGUST‐AHF Study
por: Zhang, Jingjing, et al.
Publicado: (2020)

Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHF
por: Liu, Licette C. Y., et al.
Publicado: (2016)

A combined clinical and biomarker approach to predict diuretic response in acute heart failure
por: ter Maaten, Jozine M., et al.
Publicado: (2015)

Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin–angiotensin–aldosterone system in patients with heart failure
por: Boorsma, Eva M., et al.
Publicado: (2021)

Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study
por: Dauw, Jeroen, et al.
Publicado: (2021)

Larissa Heart Failure Risk Score and Mode of Death in Acute Heart Failure: Insights from REALITY-AHF
por: Xanthopoulos, Andrew, et al.
Publicado: (2023)

Clinical Characteristics and Outcome of Acute Heart Failure in Korea: Results from the Korean Acute Heart Failure Registry (KorAHF)
por: Lee, Sang Eun, et al.
Publicado: (2017)

Current and novel renal biomarkers in heart failure
por: Damman, Kevin, et al.
Publicado: (2011)

Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome—an analysis from RELAX-AHF
por: Voors, Adriaan A, et al.
Publicado: (2014)

Hepatorenal dysfunction identifies high‐risk patients with acute heart failure: insights from the RELAX‐AHF trial
por: Biegus, Jan, et al.
Publicado: (2019)

Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial
por: Filippatos, Gerasimos, et al.
Publicado: (2017)

Role of Early Assesment of Diuresis and Natriuresis in Detecting In-Hospital Diuretic Resistance in Acute Heart Failure
por: García-Magallón, Belén, et al.
Publicado: (2022)

Impact of B‐lines‐guided intensive heart failure management on outcome of discharged heart failure patients with residual B‐lines
por: Zhu, Yunlong, et al.
Publicado: (2022)

Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial
por: Filippatos, Gerasimos, et al.
Publicado: (2014)

The genomics of heart failure: design and rationale of the HERMES consortium
por: Lumbers, R. Thomas, et al.
Publicado: (2021)

The time-to-treatment concept in acute heart failure: Lessons and implications from REALITY-AHF
por: Kagiyama, Nobuyuki, et al.
Publicado: (2018)

Impact of Cardiac Troponin Elevation on Mortality of Patients with Acute Heart Failure: Insights from the Korea Acute Heart Failure (KorAHF) Registry
por: Lee, Nuri, et al.
Publicado: (2022)

Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction
por: Matsue, Yuya, et al.
Publicado: (2017)

The transition from hypertension to hypertensive heart disease and heart failure: the PREFERS Hypertension study
por: Ekström, Mattias, et al.
Publicado: (2020)

Rationale and design of a risk‐guided strategy for reducing readmissions for acute decompensated heart failure: the Risk‐HF study
por: Zisis, Georgios, et al.
Publicado: (2020)

Inferior vena cava ultrasound in acute decompensated heart failure: design rationale of the CAVA‐ADHF‐DZHK10 trial
por: Jobs, Alexander, et al.
Publicado: (2020)

Adrenomedullin in heart failure: pathophysiology and therapeutic application
por: Voors, Adriaan A., et al.
Publicado: (2018)

Rationale and design of a randomized, double‐blind, event‐driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial
por: Zannad, Faiez, et al.
Publicado: (2015)

Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction: Results from The Korea Acute Heart Failure (KorAHF) Registry
por: Kim, Sung-Hwan, et al.
Publicado: (2018)

Catheter ablation for atrial fibrillation in patients with end‐stage heart failure and eligibility for heart transplantation
por: Sohns, Christian, et al.
Publicado: (2020)

Kyoto Congestive Heart Failure (KCHF) study: rationale and design
por: Yamamoto, Erika, et al.
Publicado: (2017)

Clinical implications of low estimated protein intake in patients with heart failure
por: Streng, Koen W., et al.
Publicado: (2022)

Albuminuria as a marker of systemic congestion in patients with heart failure
por: Boorsma, Eva M, et al.
Publicado: (2022)

Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF study
por: Meyer, Sven, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_222q8e877t8naofkoa288e609e